Cannabinoids and their therapeutic applications in mental disorders
.

Abstract:

:Mental disorders represent a significant public health burden worldwide due to their high prevalence, chronically disabling nature, and substantial impact on quality of life. Despite growing knowledge of the pathological mechanisms that underlie the development of these disorders, a high percentage of patients do not respond to first-line clinical treatments; thus, there is a strong need for alternative therapeutic approaches. During the past half-century, after the identification of the endocannabinoid system and its role in multiple physiological processes, both natural and synthetic cannabinoids have attracted considerable interest as putative medications in pathological conditions such as, but not exclusive to, mental disorders. Here, we provide a summary of cannabinoid effects in support of possible therapeutic applications for major depression, bipolar disorder, anxiety, posttraumatic stress disorder, and schizophrenia. Considering this evidence, highlighted benefits and risks of cannabinoid use in the management of these illnesses require further experimental study.
. :Los trastornos mentales representan una carga importante para la salud pública en todo el mundo debido a su alta prevalencia, su naturaleza crónica con discapacidad y su impacto significativo en la calidad de vida. A pesar del creciente conocimiento de los mecanismos patológicos que subyacen al desarrollo de estos trastornos, un alto porcentaje de pacientes no responde a los tratamientos clínicos de primera línea; por lo que existe una gran necesidad de enfoques terapéuticos alternativos. Durante los últimos cincuenta años, después de la identificación del sistema endocannabinoide y su papel en múltiples procesos fisiológicos, tanto los cannabinoides naturales como los sintéticos han concentrado un alto interés como posibles fármacos para trastornos mentales y otras patologías. En este artículo se resumen los efectos de los cannabinoides en apoyo de posibles aplicaciones terapéuticas para la depresión mayor, el trastorno bipolar, la ansiedad, el trastorno por estrés postraumático y la esquizofrenia. Teniendo en cuenta esta evidencia, el destacar tanto los riesgos como los beneficios del empleo de los cannabinoides en el tratamiento de estas enfermedades requiere de más trabajo experimental. :La prévalence élevée des troubles mentaux, leur chronicité et leur impact important sur la qualité de vie pèsent significativement sur la santé publique mondiale. La connaissance des mécanismes pathologiques qui sous-tendent ces troubles a progressé mais, un pourcentage élevé de patients ne répondant pas aux traitements de première ligne, d’autres approches thérapeutiques sont indispensables. L’étude du système endocannabinoïde et la mise en évidence de son rôle dans de multiples processus physiologiques au cours des cinquante dernières années, ont fortement attiré l’attention sur les cannabinoïdes naturels et synthétiques en tant que médicaments potentiels dans certaines pathologies comme, entre autres, les troubles mentaux. Nous résumons dans cet article les effets cannabinoϊdes qui pourraient s’inscrire dans le traitement de la dépression majeure, des troubles bipolaires, de l’anxiété, de l’état de stress post-traumatique et de la schizophrénie. Ces arguments nous incitent à explorer davantage les avantages et les risques des cannabinoïdes dans la prise en charge de ces maladies.

authors

Scherma M,Muntoni AL,Riedel G,Fratta W,Fadda P

doi

10.31887/DCNS.2020.22.3/pfadda

subject

Has Abstract

pub_date

2020-09-01 00:00:00

pages

271-279

issue

3

eissn

1294-8322

issn

1958-5969

journal_volume

22

pub_type

杂志文章
  • Biomarkers in development of psychotropic drugs.

    abstract::Biomarkers have been receiving increasing attention, especially in the field of psychiatry In contrast to the availability of potent therapeutic tools including pharmacotherapy, psychotherapy, and biological therapies, unmet needs remain in terms of onset of action, stability of response, and further improvement of th...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Wiedemann K

    更新日期:2011-01-01 00:00:00

  • Epigenetic signaling in psychiatric disorders: stress and depression.

    abstract::Psychiatric disorders are complex multifactorial disorders involving chronic alterations in neural circuit structure and function. While genetic factors play a role in the etiology of disorders such as depression, addiction, and schizophrenia, relatively high rates of discordance among identical twins clearly point to...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Bagot RC,Labonté B,Peña CJ,Nestler EJ

    更新日期:2014-09-01 00:00:00

  • Aspects of sleep disorders in children and adolescents.

    abstract::Sleep disorders in children and adolescents is a topic that has been, and remains, neglected in both public health education and professional training. Although much knowledge has been accumulated in recent times, it has been poorly disseminated and, therefore, relatively little is put into practice. Only some general...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Stores G

    更新日期:2009-01-01 00:00:00

  • Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk.

    abstract::We review critical trends in imaging genetics as applied to schizophrenia research, and then discuss some future directions of the field. A plethora of imaging genetics studies have investigated the impact of genetic variation on brain function, since the paradigm of a neuroimaging intermediate phenotype for schizophr...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Birnbaum R,Weinberger DR

    更新日期:2013-09-01 00:00:00

  • Depression in late life: psychiatric-medical comorbidity.

    abstract::The links between late-life depression and the medical comorbidities that are often associated with it can be divided into two paths. The path from medical illness to depression reflects general mechanisms related to stress, disability, and loss, as well as more specific physiological mechanisms, including those relat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Katz IR

    更新日期:1999-09-01 00:00:00

  • Descriptive psychopathology, phenomenology, and the legacy of Karl Jaspers.

    abstract::With his early publications (1910-1913), Karl Jaspers created a comprehensive methodological arsenal for psychiatry, thus laying the foundation for descriptive psychopathology. Following Edmund Husserl, the founder of philosophical phenomenology, Jaspers introduced phenomenology into psychopathology as "static underst...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 传,历史文章,杂志文章

    doi:

    authors: Häfner H

    更新日期:2015-03-01 00:00:00

  • Ethology and the biological correlates of mood.

    abstract::The insights of ethology-the science of animal behavior from a biological and psychological point of view-were incorporated in the 1950s by the British developmental psychiatrist, John Bowlby, into his attachment theory, which argued that a secure affective base in infancy was critical to the normal development of per...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Cyrulnik B

    更新日期:2005-01-01 00:00:00

  • The impact of classification on psychopharmacology and biological psychiatry.

    abstract::Nosological classification in psychiatry, as it is currently applied, does not facilitate biological and psychopharmacological research.• Syndromal acuity has disappeared. Consequently, it is impossible to determine: (i) vi/hether a particular drug affects a particular symptom configuration; (ii) what exactly the beha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: van Praag HM

    更新日期:1999-12-01 00:00:00

  • Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.

    abstract::There is mounting evidence that recurrent mood disorders - once considered "good prognosis diseases"- are, in fact, often very severe and life-threatening illnesses. Furthermore, although mood disorders have traditionally been conceptualized as neurochemical disorders, there is now evidence from a variety of sources d...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Quiroz JA,Manji HK

    更新日期:2002-03-01 00:00:00

  • Patient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatment.

    abstract::Post-traumatic stress disorder (PTSD) may be associated with long-lasting psychological suffering, distressing psychosocial disability, markedly reduced health-related quality of life, and increased morbidity and mortality in a subgroup of individuals in the aftermath of serious traumatic events. Both etiopathogenesis...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Kapfhammer HP

    更新日期:2014-06-01 00:00:00

  • Behavioral disturbances in Parkinson's disease.

    abstract::Treatment of Parkinson's disease (PD) is complex and often involves addressing behavioral changes in addition to the movement disorder. Patients with PD are susceptible to any psychiatric condition seen in the general population; some disorders, such as depression and anxiety, may result from PD-related neuropathologi...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Anderson KE

    更新日期:2004-09-01 00:00:00

  • The role of circadian clock genes in mental disorders.

    abstract::The study of molecular clock mechanisms in psychiatric disorders is gaining significant interest due to data suggesting that a misalignment between the endogenous circadian system and the sleep-wake cycle might contribute to the clinical status of patients suffering from a variety of psychiatric disorders. Sleep distu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Lamont EW,Legault-Coutu D,Cermakian N,Boivin DB

    更新日期:2007-01-01 00:00:00

  • Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism.

    abstract::Alcohol dependence is a frequent, chronic, relapsing, and incurable disease with enormous societal costs. Thus, alcoholism therapy and research into its outcome are of major importance for public health. The present article will: (i) give a brief overview of the epidemiology, pathogenesis, and treatment outcomes of al...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章

    doi:

    authors: Krampe H,Stawicki S,Hoehe MR,Ehrenreich H

    更新日期:2007-01-01 00:00:00

  • Genetics of generalized anxiety disorder and related traits.

    abstract::This review serves as a systematic guide to the genetics of generalized anxiety disorder (GAD) and further focuses on anxiety-relevant endophenotypes, such as pathological worry fear of uncertainty, and neuroticism. We inspect clinical genetic evidence for the familialityl heritability of GAD and cross-disorder phenot...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Gottschalk MG,Domschke K

    更新日期:2017-06-01 00:00:00

  • Pharmacological models in Alzheimer's disease research.

    abstract::Wider use of pharmacological models would facilitate the development of new drugs for Alzheimer's disease (AD), The two main models currently used are based on the cholinergic and glutamatergic hypotheses of AD, Although they lead to some of the attention and memory impairment observed in AD, they do not fully reprodu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Gilles C,Ertlé S

    更新日期:2000-09-01 00:00:00

  • A brief review of the genetics and pharmacogenetics of opioid use disorders.

    abstract::Increased physician prescribing of opioids to treat chronic nonprogressive pain has been accompanied by an increase in opioid addiction. Twin studies of opioid addiction are consistent with an inherited component of risk, approximately 50%. Several genome-wide association study (GWAS) reports indicate that genetic ris...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Berrettini W

    更新日期:2017-09-01 00:00:00

  • Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.

    abstract::Major depressive disorder (MDD) is a major public health concern. Despite tremendous advances, the pathogenic mechanisms associated with MDD are still unclear. Moreover, a significant number of MDD subjects do not respond to the currently available medication. MicroRNAs (miRNAs) are a class of small noncoding RNAs tha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Dwivedi Y

    更新日期:2014-03-01 00:00:00

  • Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches.

    abstract::We carried out two studies to test the hypothesis that altered central serotonergic function, as assessed by lower prolactin (PRL) response to fenfluramine (D-FEN), is more closely associated with suicidal behavior than a particular psychiatric diagnosis. A D-FEN test was performed in 85 major depressed inpatients, 33...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Corrêa H,Romano-Silva MA,Duval F,Campi-Azevedo AC,Lima V,Macher JP

    更新日期:2002-12-01 00:00:00

  • The epidemiology of anxiety disorders: a review.

    abstract::Epidemiological studies show that anxiety disorders are highly prevalent and an important cause of functional impairment; they constitute the most frequent menial disorders in the community. Phobias are the most common with the highest rates for simple phobia and agoraphobia. Panic disorder (PD) and obsessive-compulsi...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Martin P

    更新日期:2003-09-01 00:00:00

  • An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders.

    abstract::Inborn errors of metabolism (IEMs) are particularly frequent as diseases of the nervous system. In the pediatric neurologic presentations of IEMs neurodevelopment is constantly disturbed and in fact, as far as biochemistry is involved, any kind of monogenic disease can become an IEM. Clinical features are very diverse...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Saudubray JM,Garcia-Cazorla A

    更新日期:2018-12-01 00:00:00

  • The relationship between stress and infertility.

    abstract::The relationship between stress and infertility has been debated for years. Women with infertility report elevated levels of anxiety and depression, so it is clear that infertility causes stress. What is less clear, however, is whether or not stress causes infertility. The impact of distress on treatment outcome is di...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Rooney KL,Domar AD

    更新日期:2018-03-01 00:00:00

  • Epilepsy research: a window onto function to and dysfunction of the human brain.

    abstract::As one of the most common neurological disorders, epilepsy has devastating behavioral, social, and occupational consequences and is associated with accumulating brain damage and neurological deficits. Epilepsy comprises a large number of syndromes, which vary greatly with respect to their etiology and clinical feature...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beck H,Elger CE

    更新日期:2008-01-01 00:00:00

  • Diagnostic classification of psychiatric disorders and familial-genetic research.

    abstract::The validity of diagnostic definitions in psychiatry is directly related to the extent to which their etiology can be specified. However, since detailed knowledge of causal or susceptibility factors is lacking for most psychiatric disorders with a known or suspected familial-genetic origin, the current widely accepted...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Maier W

    更新日期:1999-12-01 00:00:00

  • The therapeutic transnosological use of psychotropic drugs.

    abstract::The current clinical use of psychotropic drugs is transnosologically oriented. This is facilitated by the current classification of mental disorders (International Classification of Diseases, 10th Revision [ICD-10]) and is perhaps justified if depression and psychosis (taken here as examples) are considered as being c...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Ackenheil M,Montane Jaime LK

    更新日期:1999-12-01 00:00:00

  • Alternative and complementary approaches in psychiatry: beliefs versus evidence.

    abstract::While the legitimacy of medical treatments is more and more questioned, one sees a paradoxical increase in nonconventional approaches, notably so in psychiatry. Over time, approaches that were considered valuable by the scientific community were found to be inefficacious, while other approaches, labelled as alternativ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 历史文章,杂志文章,评审

    doi:

    authors: Schulz P,Hede V

    更新日期:2018-09-01 00:00:00

  • Alcoholism: the dissection for endophenotypes.

    abstract::Alcohol dependence (alcoholism) is a complex disorder attributed to the interaction of genetic and environmental factors that form a collage of "disease" predisposition, which is not identical for every alcohol-dependent individual. There is considerable evidence to demonstrate that genetic predisposition accounts for...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hines LM,Ray L,Hutchison K,Tabakoff B

    更新日期:2005-01-01 00:00:00

  • Time representations in social science.

    abstract::Time has long been a major topic of study in social science, as in other sciences or in philosophy. Social scientists have tended to focus on collective representations of time, and on the ways in which these representations shape our everyday experiences. This contribution addresses work from such disciplines as anth...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Schulz Y

    更新日期:2012-12-01 00:00:00

  • Ethical and public policy challenges for pharmacogenomics.

    abstract::It is timely to consider the ethical and social questions raised by progress in pharmacogenomics, based on the current importance of pharmacogenomics for avoidance of predictable side effects of drugs, and for correct choice of medications in certain cancers. It has been proposed that the entire population be genotype...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Gershon ES,Alliey-Rodriguez N,Grennan K

    更新日期:2014-12-01 00:00:00

  • Dementia prevention and reserve against neurodegenerative disease.

    abstract::Similar to other complex disorders, the etiology of Alzheimer disease is multifactorial and characterized by an interplay of biological and environmental risk and protective factors. Potentially modifiable risk factors have emerged from epidemiological research and strategies to prevent neurodegeneration and dementia ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Perneczky R

    更新日期:2019-03-01 00:00:00

  • Treatment mechanisms: traditional and new antipsychotic drugs.

    abstract::The first generation of antipsychotic drugs was discovered in the 1960s and 1970s, These agents were effective in treating psychosis, but were accompanied by significant side effects, including severe parkinsonism and akathisia. Second-generation antipsychotics were introduced in the 1990s, These drugs have at least e...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Tamminga CA

    更新日期:2000-09-01 00:00:00